Table 5.

Survival based on associated visceral metastasis: only 22% of patients with extraskeletal metastasis survived for more than 6 months (P-value 0.001)

Other sites metastasis with BM	Life expectancy < 6 months, number and percentage	Life expectancy > 6 months, number and percentage	Total
No other visceral metastasis	12 25.50%	35 74.50%	47 100%
Lung	10 55.60%	8 44.40%	18 100%
Liver	9 56.30%	7 43.80%	16 100%
Lymph node	6 75.00%	2 25.00%	8 100%
Brain	3 100%		3 100%
Others	1 100%		1 100%
Disseminated metastasis	14 77.80%	4 22.20%	18 100%
Total	55 49.50%	56 50.50%	111 100%